Molecular Docking of Natural Compounds as DPP-4 Inhibitors in Type 2 Diabetes: A Comprehensive Review
Abstract Dipeptidyl peptidase-4 (DPP-4) is an established therapeutic target in the treatment of type 2 diabetes mellitus (T2DM), primarily due…
Abstract Dipeptidyl peptidase-4 (DPP-4) is an established therapeutic target in the treatment of type 2 diabetes mellitus (T2DM), primarily due…
Authors: Stephen Chi-yuen Ip, Chun-wa Chan, Chun-wo Chan, Anlea Chu, Wai-wah Chung, Janesse Wing-sze Hui, Ka-Wai Ku, Wing-sze Lee, Kam-moon…
Abstract The increasing prevalence of antimicrobial resistance necessitates the development of alternative antimicrobial agents derived from natural sources. This study…
Abstract Introduction: Thyroid cancer, the most prevalent endocrine malignancy globally, poses challenges owing to the limited understanding of its molecular…
Abstract The hydroethanolic Rosa rubiginosa extract is evaluated in vitro for antioxidant, anti‐inflammatory, antiplatelet, photoprotective, and antimicrobial activities. Rich in…
Abstract Alzheimer’s disease (AD) is a disease associated with loss of brain cholinergic functions and a common cause of dementia.…
Abstract Trop2–directed antibody-drug conjugates (ADCs) show activity across epithelial cancers, yet determinants of target expression in tumors and normal tissues…
Abstract Twenty semicarbazone and thiosemicarbazone derivatives (T1–T20) were synthesized and evaluated for their inhibition of monoamine oxidases and cholinesterases. Most…
Abstract Cannabidiol (CBD) is a nonpsychoactive cannabinoid with emerging anticancer and immunomodulatory properties; however, its systems-level mechanisms in tumor-associated immune…
Abstract Cannabinoids are potential anticancer agents for the add-on treatment of malignant tumors. Here, the effects of the previously less-explored…